Med Supp pays higher commissions but MA has faster sales cycles. Here's how to decide — or sell both.
TL;DR
Med Supp pays $270–$704 FYC with 88–92% persistency; MA pays $611 flat with 78–83% persistency. Top producers use a hybrid strategy selling both.
Key Data Points
- Med Supp 13-month persistency is 88–92% vs 78–83% for Medicare Advantage
- 2026 CMS Medicare Advantage commission rate is $611 first-year
- Top Medicare producers use a hybrid Med Supp + MA strategy
Selling Medicare Supplement vs. Medicare Advantage
Every Medicare agent faces this decision: Med Supp, MA, or both? Med Supp first-year commission: $270–$704. MA: $611 flat (2026 CMS rate). Med Supp persistency: 88–92%. MA: 78–83%. Med Supp close rate: 25–35%. MA: 40–55%.
The Hybrid Strategy
Top producers sell both: lead with MA for quick wins during AEP, present Med Supp to healthier clients who qualify, cross-sell ancillaries on every appointment, and use AI quoting to show both options side-by-side.
unLocked CRM runs simultaneous MA and Medigap comparisons in a single presentation.
Med Supp vs. Medicare Advantage Selling
Factor — Med Supp — Medicare Advantage
First-Year Commission — $270–$704 — $611 flat
Persistency (13-mo) — 88–92% — 78–83%
Close Rate — 25–35% — 40–55%
Enrollment Window — Year-round — AEP/OEP/SEP
Frequently Asked Questions
Which pays more: Med Supp or Medicare Advantage?
Med Supp FYC ranges $270–$704 vs MA's $611 per user. Med Supp has higher persistency (88–92% vs 78–83%), making lifetime value higher.
Can you sell both Med Supp and Medicare Advantage?
Yes. Lead with MA for volume during AEP, present Med Supp to healthier clients, cross-sell ancillaries on every appointment.